In the last trading session, 3.49 million shares of the Milestone Pharmaceuticals Inc (NASDAQ:MIST) were traded, and its beta was 1.06. Most recently the company’s share price was $2.05, and it changed around $0.15 or 7.89% from the last close, which brings the market valuation of the company to $109.37M. MIST currently trades at a discount to its 52-week high of $2.75, offering almost -34.15% off that amount. The share price’s 52-week low was $1.12, which indicates that the current value has risen by an impressive 45.37% since then. We note from Milestone Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 2.89 million shares, with the 3-month average coming to 1.22 million.
Milestone Pharmaceuticals Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended MIST as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Milestone Pharmaceuticals Inc is expected to report earnings per share of -0.2 for the current quarter.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Instantly MIST has showed a green trend with a performance of 7.89% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.4600 on recent trading dayincreased the stock’s daily price by 16.67%. The company’s shares are currently down -13.14% year-to-date, but still down -14.94% over the last five days. On the other hand, Milestone Pharmaceuticals Inc (NASDAQ:MIST) is 0.49% up in the 30-day period. We can see from the shorts that 0.74 million shares have been sold at a short interest cover period of 0.71 day(s).
The consensus price target as assigned by Wall Street analysts is $10, which translates to bulls needing to increase their stock price by 79.5% from its current value. Analyst projections state that MIST is forecast to be at a low of $10 and a high of $10.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
Forecasts for the next quarter put sales growth at 0.00%. Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 28.21%. Milestone Pharmaceuticals Inc earnings are expected to increase by -80.60% in 2025, but the outlook is positive 2.38% per year for the next five years.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.65% of Milestone Pharmaceuticals Inc shares, and 46.69% of them are in the hands of institutional investors. The stock currently has a share float of 47.00%. Milestone Pharmaceuticals Inc stock is held by 53.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 9.9119% of the shares, which is about 4.97 million shares worth $6.56 million.
RTW INVESTMENTS, LP, with 4.9211% or 3.26 million shares worth $4.3 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Nasdaq Composite Index Fund and SPDR(R) S&P(R) International Small Cap ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 19.87 shares worth $40737.0, making up 0.04% of all outstanding shares. On the other hand, SPDR(R) S&P(R) International Small Cap ETF held roughly 19.12 shares worth around $39189.0, which represents about 0.04% of the total shares outstanding.
